Human medicines European public assessment report (EPAR): Enhertu, trastuzumab deruxtecan, Date of authorisation: 18/01/2021, Revision: 22, Status: Authorised
الصحة واللياقة البدنية
Human medicines European public assessment report (EPAR): Enhertu, trastuzumab deruxtecan, Date of authorisation: 18/01/2021, Revision: 22, Status: Authorised
Human medicines European public assessment report (EPAR): Enhertu, trastuzumab deruxtecan, Date of authorisation: 18/01/2021, Revision: 22, Status: Authorised
AAdmin
٢٠ يوليو ٢٠٢٦
1 دقيقة قراءة
